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The 2005 Disease Management Colloquium was held at Jefferson Medical College in
Philadelphia on June 21-24, 2005.
The Colloquium’s goal is to better educate government agencies, the healthcare
industry, employers, and the general public about the important role disease
management programs play in improving healthcare quality and outcomes for
persons subject to chronic conditions. The following are highlights from a number of
the morning keynote presentations.

Is There Long-term Value in Disease Management Programs?
Reflection on the 2004 CBO Report
Paul Wallace, MD
Executive Director, Care Management Institute, Kaiser Permanente
In 2004, the Congressional Budget Office (CBO) was charged with assessing whether
disease management programs could “pay for themselves.” The CBO concluded,
“There is insufficient evidence to conclude that disease management programs can
generally reduce overall health spending,” but also noted “such programs could be
worthwhile even if they did not reduce costs.”1
How does one define the value of disease management programs? The answer will
vary from stakeholder to stakeholder. “Value” is relative and subjective. Purchasers
may define value by disease management’s affordability, consumers by the care
experience, and clinicians by the clinical quality; all will assess programs in terms of
return on investment and cost-effectiveness.
Will disease management’s goal of “mass customization” be met with a return on
investment? Increasing numbers of consumers are diagnosed with chronic
conditions, and simply “harvesting” the returns may lead to price relief or
shareholder return in the short run. But only with the re-investment of these savings
can disease management companies and each stakeholder group reap the rewards
and recognize the “value” of these programs.
Is there long-term value in disease management programs?
“Unequivocally: Yes.”
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The Impact of Information Technology on Disease Management
Jeremy Nobel, MD, MPH
Faculty, Department of Health Policy and Management
Harvard School of Public Health
Information technology (IT) has a major role to play not only in health care, but in
disease management (DM). Traditional DM programs have created communication
“silos,” preventing optimal integration of care across stakeholders - DM companies,
providers, payers, and consumers. Existing DM programs are faced with other
barriers to delivering services, including standardized care vs. customized care (mass
customization), person-to-person connectivity without IT (distance and time factors),
and the high tech vs. high touch conflict.
Emerging healthcare IT has already begun to erode existing barriers and promote
improved quality of care through such means as Web-based personal health records
(PHR), home-based biometric devices (e.g., blood pressure cuffs that can send
results directly to the PHR or the provider’s electronic medical record system), and
constant (24/7) connectivity to the care team. These advances promise to improve
the exchange of key health information between patients, DM organizations, and
providers. They can identify intervention opportunities that may have been missed
without “real-time” feedback and communication. In the evolving world of healthcare
consumerism, these technologies encourage more involvement by patients in their
care.
Most Web-based health IT companies recognize that seamless transition to these
tools and services has not and will not occur.
Factors that may impede full implementation include consumer receptivity,
interoperability of various data sources, provider adoption and utilization, and return
on investment. Yet, there is great optimism that IT can flourish in health care and
further DM’s quest for improved health outcomes.
*

*

*

*

*

Disease Management National Policy Issues
Christobel E. Selecky
President, Disease Management Association of America
Chief Executive Officer, Lifemasters
Many policy issues impact the implementation of disease management (DM) within
the current healthcare system. Cost concerns, demographic factors, societal changes
and delivery systems, are key obstacles for all involved. Of particular interest to the
DM industry is the underuse of evidence-based therapies for chronic conditions.
The major goals of DM are to close the gaps in access to chronic care and to support
the control of rising healthcare costs associated with those chronic diseases. The
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Disease Management Association of America proposes to achieve this by introducing
individual interventions at a population level through the use of evidence-based care
plans and continuous patient monitoring.
Looking ahead, the DM industry must confront the challenge of using DM as a
platform to reduce underuse or misuse of medical services, and address the issue of
how DM can work in a consumer-directed healthcare system. The mandate is clear to avoid the fate of previous medical management efforts by ensuring that, “when
we grow, we grow responsibly.”
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